2FA0
HMG-CoA synthase from Brassica juncea in complex with HMG-CoA and covalently bound to HMG-CoA
Summary for 2FA0
Entry DOI | 10.2210/pdb2fa0/pdb |
Related | 2F82 2F9A 2FA3 |
Descriptor | HMG-CoA synthase, 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A (3 entities in total) |
Functional Keywords | hmgs1, hmg-coa, transferase |
Biological source | Brassica juncea |
Total number of polymer chains | 1 |
Total formula weight | 50932.45 |
Authors | Pojer, F.,Ferrer, J.L.,Richard, S.B.,Noel, J.P. (deposition date: 2005-12-06, release date: 2006-07-25, Last modification date: 2024-12-25) |
Primary citation | Pojer, F.,Ferrer, J.L.,Richard, S.B.,Nagegowda, D.A.,Chye, M.L.,Bach, T.J.,Noel, J.P. Structural basis for the design of potent and species-specific inhibitors of 3-hydroxy-3-methylglutaryl CoA synthases. Proc.Natl.Acad.Sci.Usa, 103:11491-11496, 2006 Cited by PubMed Abstract: 3-Hydroxy-3-methylglutaryl CoA synthase (HMGS) catalyzes the first committed step in the mevalonate metabolic pathway for isoprenoid biosynthesis and serves as an alternative target for cholesterol-lowering and antibiotic drugs. We have determined a previously undescribed crystal structure of a eukaryotic HMGS bound covalently to a potent and specific inhibitor F-244 [(E,E)-11-[3-(hydroxymethyl)-4-oxo-2-oxytanyl]-3,5,7-trimethyl-2,4-undecadienenoic acid]. Given the accessibility of synthetic analogs of the F-244 natural product, this inhibited eukaryotic HMGS structure serves as a necessary starting point for structure-based methods that may improve the potency and species-specific selectivity of the next generation of F-244 analogs designed to target particular eukaryotic and prokaryotic HMGS. PubMed: 16864776DOI: 10.1073/pnas.0604935103 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.49 Å) |
Structure validation
Download full validation report